dihydroxyphenylalanine and orphenadrine

dihydroxyphenylalanine has been researched along with orphenadrine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fleming, P; Hunter, KR; Makar, H1
Broe, GA; Caird, FI1
Armitage, P; Hunter, KR; Laurence, DR; Stern, GM; Whyte, RK1
Florio, V; Longo, VG1
Stern, G1
Hughes, RC; Polgar, JG; Walton, JN; Weightman, D1

Trials

3 trial(s) available for dihydroxyphenylalanine and orphenadrine

ArticleYear
Levodopa in drug-induced extrapyramidal disorders.
    Lancet (London, England), 1970, Dec-05, Volume: 2, Issue:7684

    Topics: Dihydroxyphenylalanine; Extrapyramidal Tracts; Fluphenazine; Humans; Movement Disorders; Orphenadrine; Schizophrenia

1970
Levodopa and orphenadrine hydrochloride in Parkinsonism.
    European journal of clinical pharmacology, 1971, Volume: 4, Issue:1

    Topics: Administration, Oral; Aged; Clinical Trials as Topic; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Orphenadrine; Parkinson Disease; Placebos; Time Factors

1971
Levodopa in Parkinsonism: the effects of withdrawal of anticholinergic drugs.
    British medical journal, 1971, May-29, Volume: 2, Issue:5760

    Topics: Dihydroxyphenylalanine; Drug Synergism; Drug Tolerance; Female; Humans; Male; Methods; Neurologic Manifestations; Orphenadrine; Parasympatholytics; Parkinson Disease; Salivation; Substance Withdrawal Syndrome; Time Factors; Tremor; Trihexyphenidyl

1971

Other Studies

4 other study(ies) available for dihydroxyphenylalanine and orphenadrine

ArticleYear
Levodopa for parkinsonism in elderly and demented patients.
    The Medical journal of Australia, 1973, Mar-31, Volume: 1, Issue:13

    Topics: Activities of Daily Living; Aged; Cardiovascular Diseases; Dementia; Dihydroxyphenylalanine; Drug Synergism; Female; Gastrointestinal Diseases; Humans; Male; Orphenadrine; Parkinson Disease; Psychiatric Status Rating Scales

1973
Effects of amantadine and of some synthetic antiparkinsonian drugs on the behavioral response to L-DOPA in mice.
    Physiology & behavior, 1971, Volume: 6, Issue:4

    Topics: Amantadine; Amitriptyline; Animals; Antiparkinson Agents; Atropine; Behavior, Animal; Dihydroxyphenylalanine; Diphenhydramine; Drug Synergism; Imipramine; Mice; Orphenadrine; Parasympatholytics; Pargyline; Trihexyphenidyl

1971
Parkinsonism and dopa.
    The New Zealand medical journal, 1969, Volume: 69, Issue:444

    Topics: Dihydroxyphenylalanine; Humans; New Zealand; Orphenadrine; Parkinson Disease; Parkinson Disease, Postencephalitic; Trihexyphenidyl

1969
Parkinsonism.
    British medical journal, 1969, Nov-29, Volume: 4, Issue:5682

    Topics: Agranulocytosis; Dihydroxyphenylalanine; Humans; Middle Aged; Nausea; Orphenadrine; Parasympatholytics; Parkinson Disease; Parkinson Disease, Postencephalitic; Vomiting

1969